Researchers at UT MD Anderson reported an AI model that uses routine imaging to identify patients at risk for serious treatment-induced lung inflammation. The work was reported by the institution’s research newsroom and supported by NIH, CPRIT, and institutional funding.
This is a research finding, not a promise that an algorithm will replace clinical judgment. Its potential value is earlier attention: if validated, a tool like this could help care teams monitor risk and respond more quickly to a difficult complication.